C1 Technology Solutions

Enable rapid gene discovery. Accelerate product development. Bring gene products to market faster. Dyadic’s proprietary C1 technology is used for gene discovery, host optimization, large-scale manufacturing, and the creation of new products for diverse markets such as animal feed, pulp and paper, food, beverages, textiles, biofuels, biochemicals and biopharmaceuticals.

Learn More

Biofuels

Develop advanced dependable bioenergy solutions. Identify novel enzymes that convert biomass into fermentable sugars for use in producing biofuels. Bring more cost-effective alternative fuel solutions to market faster. Dyadic’s C1 technology creates new development opportunities, through licensing arrangements and partnerships.

Learn More

Partnering

Break the bottlenecks in your genomic research and development programs. Accelerate product development. Improve production yields. Dyadic is interested in forming strategic partnerships to discover biomaterials, lower your costs, develop new products and bring them to market quickly.

Learn More

Industrial Enzymes

Go from gene discovery to commercial manufacturing using the same host microorganism. Use Dyadic enzymes for large-scale production of innovative products. Dyadic delivers the C1 platform technology and more than 50 enzyme products to customers worldwide.

Learn More

BiofuelsBiochemicalsBiopharmaceuticalsAnimal FeedPulp and PaperTextilesFood and BeverageNutraceuticals

Welcome to Dyadic. We are a global biotechnology company with patented and proprietary technologies that are used to discover, develop, manufacture and sell enzymes and other proteins for the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries. Dyadic’s C1 platform technology enables the development and large scale manufacture of low cost enzymes and other proteins for diverse market opportunities. Dyadic leverages the value of its technologies through licensing arrangements and other collaborations with third parties who receive the benefits of producing and using the proteins these technologies help produce. LEARN MORE


Recent News

March 27, 2014
New U.S. Patent Issued to Dyadic International
Click Here

March 24, 2014
New U.S. Patent Issued to Dyadic International
Click Here

March 18, 2014
Dyadic International Announces Participation in OPTIBIOCAT Collaboration
Click Here

March 13, 2014
Dyadic International Reports Full Year 2013 Financial Results
Click Here
Conference Call Replay

March 11, 2014
Dyadic International Joins OTCQX Marketplace
Click Here

March 10, 2014
Dyadic International Withdraws Notice of Breach Letter Relating to its C1 License Agreement with Codexis
Click Here

Upcoming Events

Coming soon

 

Videos

Mark Emalfarb Interview at LD Micro VI
Los Angeles, December 3-5, 2013